SecSonar.com

Henry Schein, Inc. (HSIC)

Henry Schein, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Henry Schein, Inc. (HSIC) is a Medical - Distribution company based in US with a market capitalization of $8.8B. Revenue grew 4.0% year-over-year and the company generated $573M in free cash flow. This page tracks HSIC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 25K employees · IPO Nov 3, 1995

Valuation

Valuation & price

$72.72 · as of May 17, 2026 · -15.9% vs 52w high

22.2

P/E ratio

Latest-FY diluted EPS

2.71

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$86.43$74.23$62.03Jul 25Dec 25Jul 26Jul 7, 25$73.45Jul 9, 25$74.16Jul 11, 25$73.42Jul 15, 25$70.64Jul 17, 25$69.50Jul 21, 25$69.07Jul 23, 25$74.19Jul 25, 25$71.46Jul 29, 25$70.05Jul 31, 25$67.65Aug 4, 25$70.02Aug 6, 25$66.32Aug 11, 25$66.10Aug 13, 25$68.99Aug 15, 25$67.84Aug 19, 25$68.31Aug 21, 25$68.21Aug 25, 25$68.47Aug 27, 25$68.98Aug 29, 25$69.58Sep 3, 25$67.13Sep 5, 25$69.43Sep 9, 25$67.65Sep 11, 25$69.55Sep 16, 25$68.39Sep 18, 25$68.55Sep 22, 25$67.92Sep 24, 25$67.75Sep 26, 25$66.06Sep 30, 25$66.37Oct 2, 25$66.03Oct 6, 25$66.04Oct 8, 25$64.73Oct 10, 25$63.17Oct 14, 25$63.39Oct 16, 25$62.03Oct 21, 25$64.23Oct 23, 25$63.59Oct 27, 25$63.54Oct 29, 25$62.32Oct 31, 25$63.20Nov 4, 25$71.61Nov 6, 25$70.06Nov 10, 25$73.00Nov 12, 25$72.84Nov 14, 25$71.43Nov 18, 25$71.20Nov 20, 25$71.18Nov 25, 25$75.50Nov 28, 25$74.57Dec 2, 25$71.67Dec 4, 25$73.34Dec 8, 25$72.86Dec 10, 25$75.88Dec 12, 25$76.55Dec 16, 25$77.05Dec 18, 25$77.02Dec 22, 25$77.58Dec 24, 25$76.19Dec 29, 25$76.44Jan 2, 26$76.82Jan 6, 26$78.55Jan 8, 26$79.00Jan 12, 26$76.13Jan 14, 26$76.26Jan 16, 26$79.98Jan 21, 26$78.94Jan 23, 26$77.21Jan 27, 26$76.87Jan 29, 26$74.34Feb 2, 26$75.31Feb 4, 26$75.26Feb 9, 26$80.10Feb 11, 26$81.69Feb 13, 26$78.19Feb 18, 26$78.03Feb 20, 26$79.57Feb 24, 26$83.35Feb 26, 26$81.47Mar 2, 26$81.37Mar 4, 26$80.58Mar 6, 26$77.60Mar 10, 26$76.29Mar 12, 26$74.97Mar 17, 26$74.87Mar 19, 26$72.68Mar 23, 26$74.46Mar 25, 26$74.25Mar 27, 26$72.10Mar 31, 26$73.70Apr 2, 26$73.94Apr 7, 26$73.85Apr 9, 26$75.62Apr 13, 26$75.99Apr 15, 26$77.42Apr 17, 26$78.83Apr 22, 26$78.11Apr 24, 26$77.54Apr 28, 26$76.12Apr 30, 26$74.59May 4, 26$72.02May 6, 26$72.44May 8, 26$70.82May 12, 26$69.35May 14, 26$72.61May 18, 26$72.69May 20, 26$73.23May 22, 26$74.21May 28, 26$76.32Jun 1, 26$76.40Jun 3, 26$75.74Jun 5, 26$77.45Jun 9, 26$80.03Jun 11, 26$80.22Jun 15, 26$81.09Jun 17, 26$79.97Jun 22, 26$78.67Jun 24, 26$82.82Jun 26, 26$84.95Jul 2, 26$86.43
$62.0352-week range$86.43
Loading valuation history…

Fundamentals

Key fundamentals

$8.8B

Market cap

4.0%

Revenue growth (YoY)

29.1%

Gross margin

$573M

Free cash flow (USD)

$3.5B

Net debt

-4.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$11.6BFY 2017$12.5BFY 2018$13.2BFY 2019$10.0BFY 2020$10.1BFY 2021$12.4BFY 2022$12.6BFY 2023$12.3BFY 2024$12.7BFY 2025$13.2B
$11.6B$13.2B

Free cash flow by year

2016 → 2025

FY 2016$545.3MFY 2017$464.0MFY 2018$594.1MFY 2019$577.9MFY 2020$550.0MFY 2021$630.6MFY 2022$506.0MFY 2023$353.0MFY 2024$661.0MFY 2025$573.0M
$545.3M$573M

Gross margin by year

2021 → 2025

FY 202129.6%FY 202228.9%FY 202329.6%FY 202429.7%FY 202529.1%
29.6%29.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsMay 22, 2026Filing
  • Insider buyInsider Buy $692KDANIEL WILLIAM K · Director · $691.9KMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing

Questions

Frequently asked questions

What is Henry Schein, Inc.'s market cap?

Henry Schein, Inc. (HSIC) has a market capitalization of $8.8B.

What is HSIC's P/E ratio?

HSIC trades at a price-to-earnings ratio of 22.2, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is HSIC's price-to-book (P/B) ratio?

HSIC trades at 2.71 times book value per share.

Are insiders buying HSIC stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at Henry Schein, Inc. in the last 90 days.

Same arena

Related companies in Medical - Distribution

GRDN

Guardian Pharmacy Services, Inc.

$2.4B

PBH

Prestige Consumer Healthcare Inc.

$2.3B

ACH

Accendra Health, Inc.

$219.4M

GEG

Great Elm Group, Inc.

$67.7M

WGRX

Wellgistics Health, Inc.

$9.2M

SNYR

Synergy CHC Corp.

$2.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.